Michael D. Goldberg
Independent ChairmanMr. Michael D. Goldberg, MBA, serves as Executive Chairman at DNAnexus Inc. since March 2023. He served as Chairman and Chief Executive Officer at Jasper Capital. He is Independent Director at CareDx, Inc from November 2011 and as its Independent Chairman from November 1, 2021 and served as its Chairman since November 2011 until January 1, 2020. He was Lead Independent Director at CareDx Inc since January 1, 2020 until November 1, 2011. Mr. Goldberg serves as an Advisor of BidShift. Mr. Goldberg led the life science investments in the areas of molecular diagnostics, personalized medicine and wireless healthcare with particular interest in oncology, cardiology and neuroscience. He also leveraged his knowledge of plant genetics and microbiology in support of its clean tech investing. Mr. Goldberg worked to extend the Mohr Davidow's reach into major universities and research centers. Mr. Goldberg has experience as an entrepreneur and Investor in early stage companies primarily in life science-related industries including biotechnology, pharmaceuticals and health services. He served as Advisor of Concerro, Incorporated. He was a General Partner of Mohr Davidow Ventures from January 2005 to May 2011. Mr. Goldberg served as a Managing Director at Jasper Capital. He served as the Chief Executive Officer until March 1999 and Chairman until August 2001 of OnCare, Inc. which he founded in 1995. Mr. Goldberg was the Founder and served as the President and Chief Executive Officer since 1987 until 1995 at Axion Inc. which he started in 1987. He was a Partner at Sevin Rosen Funds, where he had been responsible for its investments in the biomedical industry. Mr. Goldberg served as a Director of Corporate Development at Cetus Corporation from 1981 to 1985. He was a Co-Founder of Agracetus. Mr. Goldberg was responsible for the commercialization of agricultural technology. He serves as the Executive Chairman of Nodality, Inc. He served as Director and executive Chairman of the Board of Directors DNAnexus, Inc. since May 2011. He serves as a Director of eHealthInsurance; CardioDx, Crescendo Bioscience, Zyomyx, BidShift and KnowMed Systems. Mr. Goldberg operated a management and financial consultancy business from October 2000 to December 2004. He is Chairman and Director at YorLabs since 2018. Mr. Goldberg was a Partner at the venture capital firm of Sevin Rosen Management Company from 1985 to 1987. He had been a Founding Board Member of the California Institute for Regenerative Medicine since its inception in 2005. He had been an Independent Director of eHealth, Inc. since June 1999 until December 31, 2021 and served as its Lead Independent Director since April 2014. He serves as a Member of National Advisory Board at CareCounsel, LLC. He serves as a Member of Advisory Board of High Bar Capital and Solid Instance, Inc. He served as the Chairman of iRhythm Technologies, Inc. from 2007 – 2010, OnCare, Inc. He served as Director of Ventus Medical, Mohr Davidow Ventures, Inc; On-Q-ity Inc. and Concerro, Incorporated. He served as a Director Genomic Health Inc. from October 2001 to May 21, 2008. Mr. Goldberg serves on the Advisory Councils of the Caltech Division of Biology, the Harvard Center for Genetics and Genomics, the Stanford Neuroscience Institute and the Berkeley Center for Law and Technology. He serves as an Advisor to the UCSF Center for Translational and Policy Research on Personalized Medicine. Mr. Goldberg serves as a Member of the Personalized Medicine Coalition and an Honorary Trustee of the National Childhood Cancer Foundation. He was Chairman, Crescendo Biosciences from 2007 to 2010. He served as a Co-Chairman of the California Research and Cures Coalition. He served as a Director of the Western Association of Venture Capitalists. He is Advisory Board Member at Stanford Distinguished Careers Institute. Mr. Goldberg holds a B.A. in philosophy from Brandeis University and an M.B.A. from the Stanford Graduate School of Business.
Positions
- Company NameCareDx, Inc.Stock CodeCDNAPositionIndependent ChairmanColleagues
- JWJohn Walter HannaPresident, CEO & Director
- KSKeith S. KennedyCFO & COO
- JAJeffrey A. NovackGeneral Counsel & Secretary
- JMJessica MengChief Commercial Officer
- KRKashif RathoreChief Technology Officer
- CMChristine M. CournoyerIndependent Director
- RBR. Bryan RiggsbeeIndependent Director
- FEFred E. CohenIndependent Director
